Pacerone and Simvastatin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Pacerone (amiodarone hydrochloride) and Simvastatin (simvastatin). Common drug interactions include multiple injuries among females and fall among males.
The phase IV clinical study analyzes what interactions people have when they take Pacerone and Simvastatin. It is created by eHealthMe based on reports of 164 people who take the same drugs from the FDA, and is updated regularly.
What is Pacerone?
Pacerone has active ingredients of amiodarone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 2,814 Pacerone users. Check the latest studies of Pacerone.
What is Simvastatin?
Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 256,969 Simvastatin users. Check the latest studies of Simvastatin.
164 people who take Pacerone and Simvastatin together, and have interactions are studied.
What are the common drug interactions of Pacerone and Simvastatin, by gender? *
What are the common drug interactions of Pacerone and Simvastatin, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Pacerone and Simvastatin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Pacerone (2,814 reports)
- Simvastatin (256,969 reports)
Browse all drug interactions of Pacerone and Simvastatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pacerone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Simvastatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pacerone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Simvastatin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
- Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .
- Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
- Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on amiodarone hydrochloride and simvastatin (the active ingredients of Pacerone and Simvastatin, respectively), and Pacerone and Simvastatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Emla and Adriamycin Pfs - 32 seconds ago
- Could Clonidine cause Psoriatic Arthropathy Aggravated? - 37 seconds ago
- Drug interactions of Reglan and Vimpat - 43 seconds ago
- Could Dutasteride cause Liver Function Test Abnormal? - 55 seconds ago
- Drug interactions of Zestoretic and Isosorbide Mononitrate - 59 seconds ago
- Could Cimzia cause Blindness? - a minute ago
- Drug interactions of Zestoretic and Nuvigil - a minute ago
- Drug interactions of Desogestrel And Ethinyl Estradiol and Morphine Sulfate - a minute ago
- Drug interactions of Anastrozole and Tenormin - a minute ago
- Drug interactions of Diprivan and Cefazolin Sodium - a minute ago